Tachykinin neurokinin 3 receptor antagonists: a patent review (2005 – 2010)
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tachykinin neurokinin 3 receptor antagonists: a patent review (2005 – 2010)
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 21, Issue 5, Pages 637-655
Publisher
Informa Healthcare
Online
2011-03-21
DOI
10.1517/13543776.2011.568482
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of potent, balanced and orally active dual NK1/NK3 receptor ligands
- (2010) Jens-Uwe Peters et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Rational design of novel pyrrolidine derivatives as orally active neurokinin-3 receptor antagonists
- (2010) Hassen Ratni et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Neurokinin B and the hypothalamic regulation of reproduction
- (2010) Naomi E. Rance et al. BRAIN RESEARCH
- Neurokinin B Stimulates GnRH Release in the Male Monkey (Macaca mulatta) and Is Colocalized with Kisspeptin in the Arcuate Nucleus
- (2010) Suresh Ramaswamy et al. ENDOCRINOLOGY
- Future Prospects for Luteinizing Hormone-Releasing Hormone Analogues in Prostate Cancer Treatment
- (2010) Hideyuki Akaza PHARMACOLOGY
- Characterization of species-related differences in the pharmacology of tachykinin NK receptors 1, 2 and 3
- (2009) Agnes Leffler et al. BIOCHEMICAL PHARMACOLOGY
- Therapeutic Utility of NK3 Receptor Antagonists for the Treatment of Schizophrenia
- (2009) Lee Dawson et al. CURRENT PHARMACEUTICAL DESIGN
- In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics
- (2009) Lee A. Dawson et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Luteinizing hormone-releasing hormone (LHRH) agonists in the treatment of breast cancer
- (2009) Allan Hackshaw EXPERT OPINION ON PHARMACOTHERAPY
- Identification of a Critical Residue in the Transmembrane Domain 2 of Tachykinin Neurokinin 3 Receptor Affecting the Dissociation Kinetics and Antagonism Mode of Osanetant (SR 142801) and Piperidine-Based Structures
- (2009) Pari Malherbe et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ligand binding and micro-switches in 7TM receptor structures
- (2009) Rie Nygaard et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- New quinoline NK3 receptor antagonists with CNS activity
- (2008) Paul W. Smith et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Guide to Receptors and Channels (GRAC), 3rd edition
- (2008) S P H Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol
- (2008) M. Liem-Moolenaar et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Me-Talnetant and Osanetant Interact within Overlapping but Not Identical Binding Pockets in the Human Tachykinin Neurokinin 3 Receptor Transmembrane Domains
- (2008) P. Malherbe et al. MOLECULAR PHARMACOLOGY
- TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction
- (2008) A Kemal Topaloglu et al. NATURE GENETICS
- Cognitive performance in neurokinin 3 receptor knockout mice
- (2008) R. E. Nordquist et al. PSYCHOPHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started